{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:51:46Z","timestamp":1790434306156,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-019-0401-1","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T20:26:26Z","timestamp":1553027186000},"page":"1024-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus"],"prefix":"10.1038","volume":"4","author":[{"given":"Atsuhiro","family":"Yasuhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5157","authenticated-orcid":false,"given":"Seiya","family":"Yamayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Sakai-Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-7347","authenticated-orcid":false,"given":"I-Hsuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-8296","authenticated-orcid":false,"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"401_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/289366a0","volume":"289","author":"IA Wilson","year":"1981","unstructured":"Wilson, I. A., Skehel, J. J. & Wiley, D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 \u00c5 resolution. Nature 289, 366\u2013373 (1981).","journal-title":"Nature"},{"key":"401_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/333426a0","volume":"333","author":"W Weis","year":"1988","unstructured":"Weis, W. et al. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333, 426\u2013431 (1988).","journal-title":"Nature"},{"key":"401_CR3","doi-asserted-by":"publisher","first-page":"e59623","DOI":"10.1371\/journal.pone.0059623","volume":"8","author":"ER Job","year":"2013","unstructured":"Job, E. R. et al. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. PLoS ONE 8, e59623 (2013).","journal-title":"PLoS ONE"},{"key":"401_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","volume":"61","author":"P Palese","year":"1974","unstructured":"Palese, P., Tobita, K., Ueda, M. & Compans, R. W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397\u2013410 (1974).","journal-title":"Virology"},{"key":"401_CR5","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H. D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 78, 12665\u201312667 (2004).","journal-title":"J. Virol."},{"key":"401_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","volume":"35","author":"CW Potter","year":"1979","unstructured":"Potter, C. W. & Oxford, J. S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35, 69\u201375 (1979).","journal-title":"Br. Med. Bull."},{"key":"401_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1017\/S0022172400022610","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 70, 767\u2013777 (1972).","journal-title":"J. Hyg."},{"key":"401_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20101352","volume":"208","author":"J Wrammert","year":"2011","unstructured":"Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181\u2013193 (2011).","journal-title":"J. Exp. Med."},{"key":"401_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","volume":"173","author":"YQ Chen","year":"2018","unstructured":"Chen, Y. Q. et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173, 417\u2013429 (2018).","journal-title":"Cell"},{"key":"401_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2006.02421.x","volume":"119","author":"M Knossow","year":"2006","unstructured":"Knossow, M. & Skehel, J. J. Variation and infectivity neutralization in influenza. Immunology 119, 1\u20137 (2006).","journal-title":"Immunology"},{"key":"401_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2017.03.007","volume":"17","author":"S Yamayoshi","year":"2017","unstructured":"Yamayoshi, S. et al. A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits influenza A virus particle release. EBioMedicine 17, 182\u2013191 (2017).","journal-title":"EBioMedicine"},{"key":"401_CR12","doi-asserted-by":"publisher","first-page":"e80034","DOI":"10.1371\/journal.pone.0080034","volume":"8","author":"B Brandenburg","year":"2013","unstructured":"Brandenburg, B. et al. Mechanisms of hemagglutinin targeted influenza virus neutralization. PLoS ONE 8, e80034 (2013).","journal-title":"PLoS ONE"},{"key":"401_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531\u2013569 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"401_CR14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/jvi.2.8.778-786.1968","volume":"2","author":"JL Schulman","year":"1968","unstructured":"Schulman, J. L., Khakpour, M. & Kilbourne, E. D. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J. Virol. 2, 778\u2013786 (1968).","journal-title":"J. Virol."},{"key":"401_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.99.1.49","volume":"99","author":"RG Webster","year":"1967","unstructured":"Webster, R. G. & Laver, W. G. Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. J. Immunol. 99, 49\u201355 (1967).","journal-title":"J. Immunol."},{"key":"401_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.antiviral.2016.10.001","volume":"135","author":"JR Wilson","year":"2016","unstructured":"Wilson, J. R. et al. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo. Antiviral Res. 135, 48\u201355 (2016).","journal-title":"Antiviral Res."},{"key":"401_CR17","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41564-017-0011-8","volume":"2","author":"TJ Wohlbold","year":"2017","unstructured":"Wohlbold, T. J. et al. Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. Nat. Microbiol. 2, 1415\u20131424 (2017).","journal-title":"Nat. Microbiol."},{"key":"401_CR18","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01035-10","volume":"84","author":"BJ Bosch","year":"2010","unstructured":"Bosch, B. J. et al. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J. Virol. 84, 10366\u201310374 (2010).","journal-title":"J. Virol."},{"key":"401_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/jvi.4.1.58-66.1969","volume":"4","author":"JT Seto","year":"1969","unstructured":"Seto, J. T. & Chang, F. S. Functional significance of sialidase during influenza virus multiplication: an electron microscope study. J. Virol. 4, 58\u201366 (1969).","journal-title":"J. Virol."},{"key":"401_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","volume":"212","author":"AS Monto","year":"2015","unstructured":"Monto, A. S. et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J. Infect. Dis. 212, 1191\u20131199 (2015).","journal-title":"J. Infect. Dis."},{"key":"401_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","volume":"1","author":"AS Monto","year":"1973","unstructured":"Monto, A. S. & Kendal, A. P. Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1, 623\u2013625 (1973).","journal-title":"Lancet"},{"key":"401_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","volume":"126","author":"DJ DiLillo","year":"2016","unstructured":"DiLillo, D. J., Palese, P., Wilson, P. C. & Ravetch, J. V. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605\u2013610 (2016).","journal-title":"J. Clin. Invest."},{"key":"401_CR23","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.4049\/jimmunol.130.5.2133","volume":"130","author":"B Perussia","year":"1983","unstructured":"Perussia, B., Starr, S., Abraham, S., Fanning, V. & Trinchieri, G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J. Immunol. 130, 2133\u20132141 (1983).","journal-title":"J. Immunol."},{"key":"401_CR24","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1002\/j.1460-2075.1989.tb08540.x","volume":"8","author":"SG Stuart","year":"1989","unstructured":"Stuart, S. G. et al. Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO J. 8, 3657\u20133666 (1989).","journal-title":"EMBO J."},{"key":"401_CR25","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.intimp.2013.06.034","volume":"17","author":"K Futosi","year":"2013","unstructured":"Futosi, K., Fodor, S. & M\u00f3csai, A. Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int. Immunopharmacol. 17, 638\u2013650 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"401_CR26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1084\/jem.20151267","volume":"212","author":"S Bournazos","year":"2015","unstructured":"Bournazos, S., DiLillo, D. J. & Ravetch, J. V. The role of Fc-Fc\u03b3R interactions in IgG-mediated microbial neutralization. J. Exp. Med. 212, 1361\u20131369 (2015).","journal-title":"J. Exp. Med."},{"key":"401_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/ni.2939","volume":"15","author":"A Pincetic","year":"2014","unstructured":"Pincetic, A. et al. Type I and type II Fc receptors regulate innate and adaptive immunity. Nat. Immunol. 15, 707\u2013716 (2014).","journal-title":"Nat. Immunol."},{"key":"401_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0042-6822(82)90244-6","volume":"122","author":"WG Laver","year":"1982","unstructured":"Laver, W. G., Air, G. M., Webster, R. G. & Markoff, L. J. Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase. Virology 122, 450\u2013460 (1982).","journal-title":"Virology"},{"key":"401_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1017\/S002217240006424X","volume":"92","author":"P Luther","year":"1984","unstructured":"Luther, P., Bergmann, K. C. & Oxford, J. S. An investigation of antigenic drift of neuraminidases of influenza A (H1N1) viruses. J. Hyg. 92, 223\u2013229 (1984).","journal-title":"J. Hyg."},{"key":"401_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/296115a0","volume":"296","author":"RG Webster","year":"1982","unstructured":"Webster, R. G., Laver, W. G., Air, G. M. & Schild, G. C. Molecular mechanisms of variation in influenza viruses. Nature 296, 115\u2013121 (1982).","journal-title":"Nature"},{"key":"401_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0042-6822(85)90157-6","volume":"145","author":"GM Air","year":"1985","unstructured":"Air, G. M., Els, M. C., Brown, L. E., Laver, W. G. & Webster, R. G. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase. Virology 145, 237\u2013248 (1985).","journal-title":"Virology"},{"key":"401_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/303041a0","volume":"303","author":"PM Colman","year":"1983","unstructured":"Colman, P. M., Varghese, J. N. & Laver, W. G. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303, 41\u201344 (1983).","journal-title":"Nature"},{"key":"401_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1006\/viro.2000.0578","volume":"276","author":"TG Fanning","year":"2000","unstructured":"Fanning, T. G., Reid, A. H. & Taubenberger, J. K. Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions. Virology 276, 417\u2013423 (2000).","journal-title":"Virology"},{"key":"401_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"401_CR35","doi-asserted-by":"publisher","first-page":"e55561","DOI":"10.1371\/journal.pone.0055561","volume":"8","author":"L Simonelli","year":"2013","unstructured":"Simonelli, L. et al. Rational engineering of a human anti-dengue antibody through experimentally validated computational docking. PLoS ONE 8, e55561 (2013).","journal-title":"PLoS ONE"},{"key":"401_CR36","unstructured":"Wright P., Neumann G. & Kawaoka Y. in Field Virology 5th edn, vol. 2 (eds Knipe, D. M. & Howley, P. M.) 1691\u20131740 (Lippincott Williams & Wilkins, Philadelphia, 2007)."},{"key":"401_CR37","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1128\/CVI.00428-10","volume":"18","author":"K Iwatsuki-Horimoto","year":"2011","unstructured":"Iwatsuki-Horimoto, K. et al. Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan. Clin. Vaccine Immunol. 18, 860\u2013866 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"401_CR38","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","volume":"286","author":"BR Murphy","year":"1972","unstructured":"Murphy, B. R., Kasel, J. A. & Chanock, R. M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N. Engl. J. Med. 286, 1329\u20131332 (1972).","journal-title":"N. Engl. J. Med."},{"key":"401_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1743-422X-5-40","volume":"5","author":"K Bragstad","year":"2008","unstructured":"Bragstad, K., Nielsen, L. P. & Fomsgaard, A. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol. J. 5, 40 (2008).","journal-title":"Virol. J."},{"key":"401_CR40","doi-asserted-by":"publisher","first-page":"e00417-16","DOI":"10.1128\/mBio.00417-16","volume":"7","author":"MJ Memoli","year":"2016","unstructured":"Memoli, M. J. et al. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model. mBio 7, e00417-16 (2016).","journal-title":"mBio"},{"key":"401_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7114","volume":"6","author":"H Wan","year":"2015","unstructured":"Wan, H. et al. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers. Nat. Commun. 6, 6114 (2015).","journal-title":"Nat. Commun."},{"key":"401_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/JVI.01756-15","volume":"90","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Comparative efficacy of monoclonal antibodies that bind to different epitopes of the 2009 pandemic H1N1 influenza virus neuraminidase. J. Virol. 90, 117\u2013128 (2015).","journal-title":"J. Virol."},{"key":"401_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbrc.2009.06.151","volume":"387","author":"R Kubota-Koketsu","year":"2009","unstructured":"Kubota-Koketsu, R. et al. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem. Biophys. Res. Commun. 387, 180\u2013185 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"401_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17986-8","volume":"7","author":"A Yasuhara","year":"2017","unstructured":"Yasuhara, A. et al. Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies. Sci. Rep. 7, 17735 (2017).","journal-title":"Sci. Rep."},{"key":"401_CR45","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345\u20139350 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"401_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virusres.2011.03.022","volume":"158","author":"S Sakabe","year":"2011","unstructured":"Sakabe, S., Ozawa, M., Takano, R., Iwastuki-Horimoto, K. & Kawaoka, Y. Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. Virus Res. 158, 124\u2013129 (2011).","journal-title":"Virus Res."},{"key":"401_CR47","doi-asserted-by":"crossref","unstructured":"Yamayoshi S. et al. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human. J. Infect. 76, 177\u2013185 (2017).","DOI":"10.1016\/j.jinf.2017.12.004"},{"key":"401_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jviromet.2014.09.003","volume":"210","author":"L Couzens","year":"2014","unstructured":"Couzens, L. et al. An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera. J. Virol. Methods 210, 7\u201314 (2014).","journal-title":"J. Virol. Methods"},{"key":"401_CR49","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3201\/eid1209.060276","volume":"12","author":"GW Chen","year":"2006","unstructured":"Chen, G. W. et al. Genomic signatures of human versus avian influenza A viruses. Emerg. Infect. Dis. 12, 1353\u20131360 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"401_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","volume":"27","author":"CE Shannon","year":"1948","unstructured":"Shannon, C. E. A mathematical theory of communication. Bell Syst. Tech. J. 27, 379\u2013423 (1948).","journal-title":"Bell Syst. Tech. J."},{"key":"401_CR51","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0021-9258(18)89778-2","volume":"260","author":"Y Ottaviano","year":"1985","unstructured":"Ottaviano, Y. & Gerace, L. Phosphorylation of the nuclear lamins during interphase and mitosis. J. Biol. Chem. 260, 624\u2013632 (1985).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0401-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T17:27:33Z","timestamp":1694712453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-019-0401-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1038\/s41564-019-0401-1","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"assertion":[{"value":"2 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.K. has received speaker\u2019s honoraria from Toyama Chemical and Astellas Inc., grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Otsuka Pharmaceutical Co., Ltd. and Denka Seiken Co., Ltd., and is a co-founder of FluGen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}